Nautilus Advisors LLC Johnson & Johnson Transaction History
Nautilus Advisors LLC
- $149 Billion
- Q3 2025
A detailed history of Nautilus Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nautilus Advisors LLC holds 4,449 shares of JNJ stock, worth $887,931. This represents 0.56% of its overall portfolio holdings.
Number of Shares
4,449
Previous 4,603
3.35%
Holding current value
$887,931
Previous $703 Million
17.33%
% of portfolio
0.56%
Previous 0.52%
Shares
3 transactions
Others Institutions Holding JNJ
# of Institutions
4,825Shares Held
1.74BCall Options Held
20.4MPut Options Held
17.2M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...